BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35278764)

  • 1. A complex epileptic and dysmorphic phenotype associated with a novel frameshift KDM5B variant and deletion of SCN gene cluster.
    Mangano GD; Antona V; Calì E; Fontana A; Salpietro V; Houlden H; Veggiotti P; Nardello R
    Seizure; 2022 Apr; 97():20-22. PubMed ID: 35278764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel KDM5B splice variants identified in patients with developmental disorders: Functional consequences.
    Lebrun N; Mehler-Jacob C; Poirier K; Zordan C; Lacombe D; Carion N; Billuart P; Bienvenu T
    Gene; 2018 Dec; 679():305-313. PubMed ID: 30217758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mosaic 1q32.1 microduplication identified through Chromosome Microarray Analysis: narrowing the smallest critical region including KDM5B gene found associated with neurodevelopmetal disorders.
    Miolo G; Giuffrida MG; Corona G; Capalbo A; Pivetta B; Tessitori G; Bernardini L
    Eur J Med Genet; 2019 Sep; 62(9):103558. PubMed ID: 31405577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agenesis of the Corpus Callosum with Facial Dysmorphism and Intellectual Disability in Sibs Associated with Compound Heterozygous
    Lebon S; Quinodoz M; Peter VG; Gengler C; Blanchard G; Cina V; Campos-Xavier B; Rivolta C; Superti-Furga A
    Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Intellectual Disability Risk Gene
    Pérez-Sisqués L; Bhatt SU; Matuleviciute R; Gileadi TE; Kramar E; Graham A; Garcia FG; Keiser A; Matheos DP; Cain JA; Pittman AM; Andreae LC; Fernandes C; Wood MA; Giese KP; Basson MA
    J Neurosci; 2024 May; 44(19):. PubMed ID: 38575342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human phenotype caused by biallelic KDM4B frameshift variant.
    Takada S; Silva S; Zamorano I; Pérez A; Iwabuchi C; Miyake N
    Clin Genet; 2024 Jan; 105(1):72-76. PubMed ID: 37526414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone lysine demethylase KDM5B maintains chronic myeloid leukemia via multiple epigenetic actions.
    Xue S; Lam YM; He Z; Zheng Y; Li L; Zhang Y; Li C; Mbadhi MN; Zheng L; Cheng Z; Liu Y; Wang X; Chan LC; Ng RK; Zhang J
    Exp Hematol; 2020 Feb; 82():53-65. PubMed ID: 32007477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic KDM5B variants in the context of developmental disorders.
    Harrington J; Wheway G; Willaime-Morawek S; Gibson J; Walters ZS
    Biochim Biophys Acta Gene Regul Mech; 2022 Jul; 1865(5):194848. PubMed ID: 35905858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone demethylase KDM5B is a key regulator of genome stability.
    Li X; Liu L; Yang S; Song N; Zhou X; Gao J; Yu N; Shan L; Wang Q; Liang J; Xuan C; Wang Y; Shang Y; Shi L
    Proc Natl Acad Sci U S A; 2014 May; 111(19):7096-101. PubMed ID: 24778210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUMOylation negatively modulates target gene occupancy of the KDM5B, a histone lysine demethylase.
    Bueno MT; Richard S
    Epigenetics; 2013 Nov; 8(11):1162-75. PubMed ID: 23970103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The histone-H3K4-specific demethylase KDM5B binds to its substrate and product through distinct PHD fingers.
    Klein BJ; Piao L; Xi Y; Rincon-Arano H; Rothbart SB; Peng D; Wen H; Larson C; Zhang X; Zheng X; Cortazar MA; Peña PV; Mangan A; Bentley DL; Strahl BD; Groudine M; Li W; Shi X; Kutateladze TG
    Cell Rep; 2014 Jan; 6(2):325-35. PubMed ID: 24412361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PHD1 finger of KDM5B recognizes unmodified H3K4 during the demethylation of histone H3K4me2/3 by KDM5B.
    Zhang Y; Yang H; Guo X; Rong N; Song Y; Xu Y; Lan W; Zhang X; Liu M; Xu Y; Cao C
    Protein Cell; 2014 Nov; 5(11):837-50. PubMed ID: 24952722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
    Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
    BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel BCL11A variants in patients with epileptic encephalopathy: Expanding the phenotypic spectrum.
    Yoshida M; Nakashima M; Okanishi T; Kanai S; Fujimoto A; Itomi K; Morimoto M; Saitsu H; Kato M; Matsumoto N; Chiyonobu T
    Clin Genet; 2018 Feb; 93(2):368-373. PubMed ID: 28589569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-dependent epileptic encephalopathy associated with an unusual co-occurrence of ZEB2 and SCN1A variants.
    Nardello R; Fontana A; Mangano GD; Efthymiou S; Salpietro V; Houlden H; Mangano S
    Epileptic Disord; 2020 Feb; 22(1):111-115. PubMed ID: 32031527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haploinsufficiency of the Sin3/HDAC corepressor complex member SIN3B causes a syndromic intellectual disability/autism spectrum disorder.
    Latypova X; Vincent M; Mollé A; Adebambo OA; Fourgeux C; Khan TN; Caro A; Rosello M; Orellana C; Niyazov D; Lederer D; Deprez M; Capri Y; Kannu P; Tabet AC; Levy J; Aten E; den Hollander N; Splitt M; Walia J; Immken LL; Stankiewicz P; McWalter K; Suchy S; Louie RJ; Bell S; Stevenson RE; Rousseau J; Willem C; Retiere C; Yang XJ; Campeau PM; Martinez F; Rosenfeld JA; Le Caignec C; Küry S; Mercier S; Moradkhani K; Conrad S; Besnard T; Cogné B; Katsanis N; Bézieau S; Poschmann J; Davis EE; Isidor B
    Am J Hum Genet; 2021 May; 108(5):929-941. PubMed ID: 33811806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel FBXO28 frameshift mutation in a child with developmental delay, dysmorphic features, and intractable epilepsy: A second gene that may contribute to the 1q41-q42 deletion phenotype.
    Balak C; Belnap N; Ramsey K; Joss S; Devriendt K; Naymik M; Jepsen W; Siniard AL; Szelinger S; Parker ME; Richholt R; Izatt T; LaFleur M; Terraf P; Llaci L; De Both M; Piras IS; Rangasamy S; Schrauwen I; Craig DW; Huentelman M; Narayanan V
    Am J Med Genet A; 2018 Jul; 176(7):1549-1558. PubMed ID: 30160831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel de novo frameshift variant in SETD1B causes epilepsy.
    Den K; Kato M; Yamaguchi T; Miyatake S; Takata A; Mizuguchi T; Miyake N; Mitsuhashi S; Matsumoto N
    J Hum Genet; 2019 Aug; 64(8):821-827. PubMed ID: 31110234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leveraging blood serotonin as an endophenotype to identify de novo and rare variants involved in autism.
    Chen R; Davis LK; Guter S; Wei Q; Jacob S; Potter MH; Cox NJ; Cook EH; Sutcliffe JS; Li B
    Mol Autism; 2017; 8():14. PubMed ID: 28344757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
    Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
    Mol Autism; 2019; 10():35. PubMed ID: 31649809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.